ESR1 c.*584C>T

Variant ID: 6-152420685-C-T

NM_000125.3(ESR1):c.*584C>T

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Beneficial effects of mifepristone treatment in breast cancer patients selected by the progesterone receptor isoform ratio: Results from the MIPRA trial.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Elía, Andrés A; Saldain, Leo L; Vanzulli, Silvia I SI; Helguero, Luisa A LA; Lamb, Caroline A CA; Fabris, Victoria V; Pataccini, Gabriela G; Martínez-Vazquez, Paula P; Burruchaga, Javier J; Caillet-Bois, Ines I; Spengler, Eunice E; Acosta Haab, Gabriela G; Liguori, Marcos M; Castets, Alejandra A; Lovisi, Silvia S; Abascal, María F MF; Novaro, Virginia V; Sánchez, Jana J; Muñoz, Javier J; Belizán, Jose M JM; Abba, Martín C MC; Gass, Hugo H; Rojas, Paola P; Lanari, Claudia C
Publication Date: 2022-10-21

Variant appearance in text: rs33986155
PubMed Link: 36269797
Variant Present in the following documents:
  • ccr-22-2060_supplementary_table_s5_suppts5.xlsx, sheet 1
View BVdb publication page



A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS.

Bmc Genomics
Richardson, Kris K; Lai, Chao-Qiang CQ; Parnell, Laurence D LD; Lee, Yu-Chi YC; Ordovas, Jose M JM
Publication Date: 2011-10-13

Variant appearance in text: rs33986155
PubMed Link: 21995669
Variant Present in the following documents:
  • Main text
  • 1471-2164-12-504.pdf
View BVdb publication page